Intravitreal cortisone injection for refractory diffuse diabetic macular edema

Ophthalmologica

Volumn 219, Issue 6, 2005, Pages 394-400

  Er, Hamdi ^a,b   Yilmaz, Harun ^a  

^a INONU UNIVERSITY   (Turkey)

^b INONU UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Diabetes; Diffuse macular edema; Intravitreal cortisone; Laser coagulation

Indexed keywords

ANTIGLAUCOMA AGENT; CORTISONE; KENAKORT A; TRIAMCINOLONE ACETONIDE;

ADULT; AGED; ARTICLE; CATARACT; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFICACY; DRUG SAFETY; ENDOPHTHALMITIS; EYE; FEMALE; FOLLOW UP; HUMAN; INTRAOCULAR PRESSURE; LASER COAGULATION; MALE; RETINA MACULA EDEMA; STATISTICAL SIGNIFICANCE; VISUAL ACUITY;

ADULT; AGED; DIABETIC RETINOPATHY; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; INJECTIONS; LASER COAGULATION; MACULAR EDEMA, CYSTOID; MALE; MIDDLE AGED; RETREATMENT; TREATMENT OUTCOME; TRIAMCINOLONE ACETONIDE; VISUAL ACUITY; VITREOUS BODY;

EID: 27744499327     PISSN: 00303755     EISSN: None     Source Type: Journal    
DOI: 10.1159/000088385     Document Type: Article

References (19)

1. Klein R, Klein BE, Moss SE, Cruickshanks KJ: The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XV. The long-term incidence of macular edema. Ophthalmology 1995;102:7-16.
2. Tanaka Y, Katoh S, Hori S, Miura M, Yamashita H: Vascular endothelial growth factor in diabetic retinopathy. Lancet 1997;349:1520.
3. Doǧanay S, Evereklioǧlu C, Er H, Turkoz Y, Sevinç A, Mehmet N, Şavli H: Comparison of serum NO, TNF-alpha, IL-1beta, SIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus. Eye 2002;16: 163-170.
4. Early Treatment Diabetic Retinopathy Study Research Group: Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study Report No 1. Arch Ophthalmol 1985;103:473-478.
5. Danis RP, Ciulla TA, Pratt LM, Anliker W: Intravitreal triamcinolone acetonide in exudative age-related macular degeneration. Retina 2000;20:244-250.
6. Antcliff RJ, Spalton DJ, Stanford MR, Graham EM, Ffytche TJ, Marshall J: Intravitreal triamcinolone for uvetic cystoid macular edema: An optical coherence tomography study. Ophthalmology 2001;108:765-772.
7. Machemer R, Sugita G, Tano Y: Treatment of intraocular proliferations with intravitreal steroids. Trans Am Ophthalmol Soc 1979;77: 171-180.
8. Aiello LP, Avery RL, Arrigg PG, et al: Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994;331:1480-1487.
9. Hikichi T, Fujio N, Akiba J, et al: Association between the short-term natural history of diabetic macular edema and the vitreomacular relationship in type II diabetes mellitus. Ophthalmology 1997;104:473-478.
10. Yamamoto T, Akabane N, Takeuchi S: Vitrectomy for diabetic macular edema: The role of posterior vitreous detachment and epimacular membrane. Am J Ophthalmol 2001;132:369-377.
11. Yamamoto T, Yamamoto S, Takeuchi S: Pars plana vitrectomy for diabetic macular edema with posterior vitreous detachment. J Eye 2000;17:133-138.
12. Jonas JB, Hayler JK, Söfker A, Panda-Jonas S: Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative diabetic retinopathy. Am J Ophthalmol 2001;131:468-471.
13. Jonas JB, Kreissig I, Söfker A, Degenring R: Inravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch Ophthalmol 2003;121:57-61.
14. Jonas JB, Söfker A: Intraocular injection of crysalline cortisone as adjunctive treatment of diabetic macular edema Am J Ophthalmol 2001;132:425-427.
15. Hida T, Chandler D, Arena JE, Machemer R: Experimental and clinical observations of the intraocular toxicity of commercial corticosteroid preparations. Am J Ophthalmol 1986; 101:190-195.
16. Kivilcim M, Peyman GA, El-Dessouky ES, Kazi AA, Cheema R, Hegazy H: Retinal toxicity of triamcinolone acetonide in silicone-filled eyes. Ophthalmic Surg Lasers 2000;31:474-478.
17. Martidis A, Duker JS, Greenberg PB, Rogers AH, Puliafito CA, Reichel E, Baumal C: Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 2002;109: 920-927.
18. Girlies MC, Simpson JM, Luo W, Penfold P, Hunyor AB, Chua W, Mitchell P, Billson F: A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration: One-year results. Arch Ophthalmol 2003;121: 667-673.
19. Jonas JB, Kreissig I, Degenring R: Intraocular pressure after intravitreal injection of triamcinolone acetonide. Br J Ophthalmol 2003;87: 24-27.